UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000008254
Receipt number R000009727
Scientific Title A randomized phase II study investigating an optimal dosing regimen of TS-1 plus CDDP plus Trastuzumab combination therapy for HER2-positive unresectable and/or recurrent gastric cancer
Date of disclosure of the study information 2012/06/25
Last modified on 2012/06/25 20:53:40

No. Disposal Last modified on Item of update
1 Insert 2012/06/25 20:55:01